Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Operating Margin: 2009-2025

Historic Operating Margin for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -13.38%.

  • Lifecore Biomedical's Operating Margin rose 894.00% to 14.62% in Q2 2025 from the same period last year, while for May 2025 it was -13.38%, marking a year-over-year decrease of 649.00%. This contributed to the annual value of -13.38% for FY2025, which is 649.00% down from last year.
  • As of FY2025, Lifecore Biomedical's Operating Margin stood at -13.38%, which was down 94.07% from -6.90% recorded in FY2024.
  • Lifecore Biomedical's Operating Margin's 5-year high stood at -6.90% during FY2024, with a 5-year trough of -21.11% in FY2023.
  • Its 3-year average for Operating Margin is -13.79%, with a median of -13.38% in 2025.
  • Its Operating Margin has fluctuated over the past 5 years, first tumbled by 1,051bps in 2023, then skyrocketed by 1,421bps in 2024.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Operating Margin stood at -8.75% in 2021, then plummeted by 185bps to -10.60% in 2022, then slumped by 1,051bps to -21.11% in 2023, then skyrocketed by 1,421bps to -6.90% in 2024, then tumbled by 649bps to -13.38% in 2025.